Eli Lilly has struck a deal to purchase genetic-medicine biotechnology firm Orna Therapeutics for as much as $2.4 billion in money.
Source link
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
Related Posts
Here’s Where AI Is Tearing Through Corporate America
The most recent advances have corporations—and the inventory market—rethinking the software program that handles jobs massive and small. Source link
Salesforce stock slumps on disappointing guidance
Salesforce CEO Marc Benioff attends the 55th annual meeting of the World Economic Forum in Davos, Switzerland, on Jan. 23,…
Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow
Blowout artificial-intelligence spending fills chip maker’s coffers, however the Groq deal exhibits that the corporate must assume creatively. Source link